Prostatic neuroendocrine tumor in multiple endocrine neoplasia Type 2B - PubMed (original) (raw)

Case Reports

Prostatic neuroendocrine tumor in multiple endocrine neoplasia Type 2B

B Goulet-Salmon et al. J Endocrinol Invest. 2004 Jun.

Abstract

We report the unusual occurrence of a neuroendocrine prostatic tumor in two young males with multiple endocrine neoplasia (MEN) 2B. Immunohistochemistry of the tumor markers may help differentiate a primary neuroendocrine prostate tumor from the metastasis of a medullary thyroid carcinoma of poor prognosis. MEN 2B hallmarks (i.e. plasma thyrocalcitonin and urinary metanephrines) may be systematically investigated in neuroendocrine tumors of the prostate, and conversely prostate examination may be performed in the periodic screening of MEN 2B male patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arch Pathol Lab Med. 1989 Jul;113(7):790-6 - PubMed
    1. Development. 1991 Dec;113(4):1093-104 - PubMed
    1. Prostate. 1989;14(1):71-81 - PubMed
    1. Scand J Urol Nephrol. 1996 Dec;30(6):503-8 - PubMed
    1. Arch Pathol Lab Med. 2001 Feb;125(2):228-31 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources